Molly Catherine Hardebeck

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

Stephen Johnston, Miguel Martín, Angelo Di Leo et al. · npj Breast Cancer · 2019 · 650 citations · Full text

Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice

Nozomi Tomimatsu, Bipasha Mukherjee, Molly Catherine Hardebeck et al. · Nature Communications · 2014 · 179 citations · Full text

Genome Instability, Signal Transduction, Cell Regulation +8

Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma

Carlos R. Gil Del Alcazar, Molly Catherine Hardebeck, Bipasha Mukherjee et al. · Clinical Cancer Research · 2013 · 168 citations · Full text

DNA-damage-induced degradation of EXO1 exonuclease limits DNA end resection to ensure accurate DNA repair

Nozomi Tomimatsu, Bipasha Mukherjee, Janelle L. Harris et al. · Journal of Biological Chemistry · 2017 · 77 citations · Full text

Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups

Stephen Johnston, Joyce O’Shaughnessy, Miguel Martín et al. · npj Breast Cancer · 2021 · 59 citations · Full text